Literature DB >> 18160271

Stevens-Johnson syndrome after treatment with capecitabine.

M A N Sendur, S Kilickap.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160271     DOI: 10.1016/j.clon.2007.11.005

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  5 in total

1.  Life-threatening dermatologic adverse events in oncology.

Authors:  Alyx C Rosen; Yevgeniy Balagula; Dennis W Raisch; Vishvas Garg; Beatrice Nardone; Nicole Larsen; Jennifer Sorrell; Dennis P West; Milan J Anadkat; Mario E Lacouture
Journal:  Anticancer Drugs       Date:  2014-02       Impact factor: 2.248

2.  A Case Report-Stevens-Johnson Syndrome as an Adverse Effect of Capecitabine.

Authors:  Priyanka Jadhav; Jane E Rogers; Rachna Shroff
Journal:  J Gastrointest Cancer       Date:  2018-09

Review 3.  Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies.

Authors:  Chau Yee Ng; Chun-Bing Chen; Ming-Ying Wu; Jennifer Wu; Chih-Hsun Yang; Rosaline Chung-Yee Hui; Ya-Ching Chang; Chun-Wei Lu
Journal:  J Immunol Res       Date:  2018-01-17       Impact factor: 4.818

4.  Stevens-Johnson syndrome and concurrent hand foot syndrome during treatment with capecitabine: A case report.

Authors:  Ha Rim Ahn; Sang-Kyung Lee; Hyun Jo Youn; Seok-Kweon Yun; Il-Jae Lee
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

5.  Capecitabine-induced radiation recall phenomenon: a case report.

Authors:  José Aguilar; Elena García; Elisa García-Garre
Journal:  F1000Res       Date:  2012-12-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.